What is Rosiglitazone?

Category: Prescription Drugs

Most popular types: Avandia

false

Rosiglitazone is an antidiabetic agent used for type 2 diabetes to improve glycemic control as an adjunct to diet and exercise. It may be used in combination when diet, exercise and a single agent do not result in adequate control. It is also used for polycystic ovary syndrome.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 0
None 2

Commonly reported side effects and conditions associated with Rosiglitazone

Side effect Patients
Weight gain 1

Dosages

Based on patients currently taking Rosiglitazone

Dosage Patients
8 mg daily 1

Why patients stopped taking Rosiglitazone

Multiple reasons could be selected

Reason Patients
Doctor's advice 5
Course of treatment ended 2
Did not seem to work 1
Other 1
Personal research 1
See all 8 patients who've stopped taking Rosiglitazone

Duration

Currently taking Rosiglitazone

Duration Patients
10 years or more 1

Stopped taking Rosiglitazone

Duration Patients
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 2
2 - 5 years 2
5 - 10 years 2
Adherence
Adherence Evaluations
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 3
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 1
$50-99 1
$25-49 0
< $25 0
Not specified 1

What people switch to and from

Patients started taking Rosiglitazone after stopping:

Treatment Patients
Glimepiride (Amaryl) 1
Glipizide (Glipizide ER) 1

Patients stopped taking Rosiglitazone and switched to:

Treatment Patients
Exenatide (Byetta) 1
Insulin Glargine (Lantus) 1
Insulin Glulisine (Apidra) 1
Metformin (Metformin ER) 1
Last updated:
There are no evaluations for Rosiglitazone.